These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 196613)

  • 1. Antibody activity to type 1 and type 2 herpes simplex virus in human cervical mucus.
    Coughlan BM; Skinner GR
    Br J Obstet Gynaecol; 1977 Aug; 84(8):622-9. PubMed ID: 196613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralising antibody against type 1 and type 2 herpes simplex virus in cervical mucus of women with cervical intra-epithelial neoplasia.
    Murphy JF; Murphy DF; Barker S; Mylotte ML; Coughlan BM; Skinner GR
    Med Microbiol Immunol; 1985; 174(2):73-80. PubMed ID: 2993833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical and serum IgA and serum IgG antibodies to Chlamydia trachomatis and herpes simplex virus in threatened abortion: a prospective study.
    Grönroos M; Honkonen E; Terho P; Punnonen R
    Br J Obstet Gynaecol; 1983 Feb; 90(2):167-70. PubMed ID: 6297535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of protein A-treated sera in unmasking herpes simplex virus type 1 (HSV-1) immunoglobulin A and identifying HSV-1 immunoglobulin G as the predominant neutralizing antibody.
    Ratner JJ; Sanford BA; Smith KO
    J Clin Microbiol; 1979 Oct; 10(4):415-8. PubMed ID: 231047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia trachomatis and herpes simplex virus IgA antibodies in cervical secretions of patients with cervical atypia.
    Kalimo K; Terho P; Honkonen E; Grönroos M; Halonen P
    Br J Obstet Gynaecol; 1981 Nov; 88(11):1130-4. PubMed ID: 6271164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG-, IgA- and IgM-antibodies to herpes simplex virus type 2 in sera from patients with cancer of the uterine cervix.
    El Falaky IH; Vestergaard BF
    Eur J Cancer (1965); 1977 Mar; 13(3):247-51. PubMed ID: 193693
    [No Abstract]   [Full Text] [Related]  

  • 7. Secretory IgA against herpes simplex virus in cervical secretions.
    Persson E; Eneroth P; Jeansson S
    Genitourin Med; 1988 Dec; 64(6):373-7. PubMed ID: 2852157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin class of antibody to herpes simplex virus in patients with oral cancer.
    Shillitoe EJ; Greenspan D; Greenspan JS; Silverman S
    Cancer; 1983 Jan; 51(1):65-71. PubMed ID: 6295594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary neutralizing activity against herpes simplex virus type 1.
    Gyselink R; Coles D; Ash RJ; Fritz ME
    J Infect Dis; 1978 May; 137(5):583-6. PubMed ID: 207786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of human antibody responses to primary genital herpes simplex virus infection.
    Kohl S; Adam E; Matson DO; Kaufman RH; Dreesman GR
    Intervirology; 1982; 18(3):164-8. PubMed ID: 6292130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neutralizing activity against herpes simplex in maternal milk].
    Lopez I; Quibriac M; Petitjean J; Bazin M; Duhamel JF; Freymuth F
    Arch Fr Pediatr; 1989 Apr; 46(4):263-5. PubMed ID: 2546513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections.
    Wang YY; Kannan A; Nunn KL; Murphy MA; Subramani DB; Moench T; Cone R; Lai SK
    Mucosal Immunol; 2014 Sep; 7(5):1036-44. PubMed ID: 24496316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic responses to herpes simplex virus in rabbits: complement-requiring neutralizing, conventional neutralizing, and passive hemagglutinating antibodies.
    Lerner AM; Shippey MJ; Crane LR
    J Infect Dis; 1974 Jun; 129(6):623-36. PubMed ID: 4365944
    [No Abstract]   [Full Text] [Related]  

  • 14. Crossed immunoelectrophoresis of sperm antibodies in human serum and cervical mucus.
    Gradl T; Mettler L
    Int J Fertil; 1975; 20(1):50-4. PubMed ID: 4387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class-specific antibodies (IgG and IgA) to membrane antigens of Herpes simplex type 2-infected cells in patients with cervical dysplasia and neoplasia.
    Mendis LN; Best JM; Banatvala JE
    Int J Cancer; 1981 May; 27(5):669-77. PubMed ID: 6270022
    [No Abstract]   [Full Text] [Related]  

  • 16. Neutralization capacity and antibody dependent cell-mediated cytotoxicity of separated IgG subclasses 1, 3 and 4 against herpes simplex virus.
    Mathiesen T; Persson MA; Sundqvist VA; Wahren B
    Clin Exp Immunol; 1988 May; 72(2):211-5. PubMed ID: 2842096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of IgA antibody to herpesvirus in cervicovaginal secretions of patients with carcinoma of the cervix.
    Dent PB; Bienenstock J
    Clin Immunol Immunopathol; 1974 Nov; 3(2):171-7. PubMed ID: 4615850
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the neutralization of herpes simplex virus. VIII. Significance of viral sensitization for inactivation by complement.
    Yoshino K; Hashimoto M; Shinkai K
    Microbiol Immunol; 1977; 21(4):231-41. PubMed ID: 195185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the neutralizing antibody to herpes simplex virus. II. Quantitative analysis of type specific antibodies in rabbits immunized with both types of virus.
    Ohashi M; Ozaki Y
    Arch Virol; 1981; 69(2):105-15. PubMed ID: 6272666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of secretory immunoglobulins in cervical mucus of women with uterine cervical dysplasia.
    Sharma BK; Gupta MM; Saha K; Luthra UK
    Indian J Med Res; 1987 Jan; 85():72-6. PubMed ID: 3034776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.